CARB:LSE-WisdomTree Carbon (EUR)

ETF | Others | LSE

Last Closing Price

EUR 10.90

Change

0.00 (0.00)%

Market Cap

EUR 0.02B

Volume

1.00K

Avg Analyst Target

N/A

Avg User Target

EUR
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

WisdomTree Carbon (CARB) Stock Analysis:
Based on the WisdomTree Carbon stock forecasts from 0 analysts, the average analyst target price for WisdomTree Carbon is not available over the next 12 months. WisdomTree Carbon’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of WisdomTree Carbon is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, WisdomTree Carbon’s stock price was EUR 10.90. WisdomTree Carbon’s stock price has changed by +0.00 % over the past week, +0.00 % over the past month and +28.24 % over the last year.

About

WisdomTree Carbon (CARB) is designed to enable investors to gain a total return exposure to movements in the price of ICE Futures' European Carbon emissions allowance futures contracts (ICE ECX CFI EUA futures contracts) plus a collateral yield. The exposure is obtained throu ...Read More

Currency: EUR

Country : UK

Management Expense Ratio: 0.49 %

Technical Indicators

52 Week High : 16.85

52 Week Low : 10.00

200 Day Moving Average : 13.91

50 Day Moving Average : 13.91

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

Morningstar Ratio : 0

Category Benchmark : -

Sustainability Ratio :

3 Year Volatility : 42.38

3 Year Expected Return : 79.81

3 Year Sharpe Ratio : 1.40

YTD Return : -9.03%

3 Year Returns : 10.79%

5 Year Returns : 9.59%

10 Year Returns : 0.00%

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-12-02 )

Largest Industry Peers for Others

Symbol Name Mer Price(Change) Market Cap
0Q1N:LSE Pfizer Inc. 0.00 %

N/A

 EUR244.23B
BOI:LSE Bank Of Ireland Group plc 13.3.. 0.00 %

N/A

 EUR238.29B
XDJP:LSE Xtrackers - Nikkei 225 UCITS E.. 0.09 %

-25.00 (-1.29%)

 EUR208.77B
LCJD:LSE Multi Units Luxembourg - Lyxor.. 0.12 %

-0.18 (-1.09%)

 EUR189.09B
LCJP:LSE Multi Units Luxembourg - Lyxor.. 0.12 %

-0.12 (-0.97%)

 EUR189.09B
LLPD:LSE Lloyds Banking Group PLC 9.75%.. 0.00 %

N/A

 EUR122.54B
LLPC:LSE Lloyds Banking Group PLC 9.25%.. 0.00 %

N/A

 EUR117.03B
UB02:LSE UBS (Lux) Fund Solutions - MSC.. 0.00 %

N/A

 EUR109.05B
UC65:LSE UBS (Lux) Fund Solutions - MSC.. 0.19 %

N/A

 EUR107.18B
JPSR:LSE UBS (Lux) Fund Solutions - MSC.. 0.22 %

-18.75 (-0.96%)

 EUR93.91B

ETFs Containing CARB

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Others)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -12.10% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.10% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 28.24% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.24% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 232.32% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 232.32% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 49.63% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 49.63% N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 84.02% N/A N/A N/A N/A
Risk Adjusted Return 59.07% N/A N/A N/A N/A
Market Capitalization 0.02B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
New Post

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike